预测特发性急性胰腺炎患者超声内镜阳性可能性的简易风险评分
该回顾性队列研究纳入3家三级中心180例特发性急性胰腺炎患者,构建DORM65评分预测超声内镜阳性。超声内镜诊断阳性率为58.9%(95%CI 51.7-66.1)。最低风险组阳性率为13.0%,最高风险组为100%(相对危险度7.67,P<.001)。评分≥3分阳性预测值86.0%,灵敏度34.9%,特异度91.9%,模型AUROCC为.774(95%CI .707-.841)。
要点
- DORM65评分基于5个预测因子:延迟超声内镜(距末次急性胰腺炎发作≥82天)、肥胖、未重复经腹超声、男性、超声内镜时年龄≥65岁。
- 最低风险组超声内镜阳性率13.0%,最高风险组100%(相对危险度7.67,P<.001)。
- 评分≥3分阳性预测值86.0%,灵敏度34.9%,特异度91.9%;模型AUROCC为.774(95%CI .707-.841)。
核心结论
- DORM65评分易于计算,能准确预测特发性急性胰腺炎患者的超声内镜阳性结果,但需进一步验证。
研究设计与样本
- 回顾性队列研究,纳入2018年1月至2021年12月期间3家三级中心180例特发性急性胰腺炎患者,采用多变量逻辑回归建模预测超声内镜阳性,以受试者工作特征曲线下面积(AUROCC)评估模型准确性。
主要发现
- 超声内镜诊断阳性率为58.9%(95%CI 51.7-66.1)。
- DORM65评分包含5个超声内镜前存在的预测因子:延迟超声内镜(距末次急性胰腺炎发作≥82天)、肥胖、未重复经腹超声、男性、超声内镜时年龄≥65岁。
- 最低风险评分组超声内镜阳性率为13.0%,最高风险组为100%(相对危险度7.67,P<.001)。
- 评分≥3分阳性预测值为86.0%,灵敏度34.9%,特异度91.9%。
- 模型预测准确性较高,AUROCC为.774(95%CI .707-.841)。
关键数值与推荐
- DORM65评分≥3分:阳性预测值86.0%,灵敏度34.9%,特异度91.9%。
- 最低风险评分组超声内镜阳性率13.0%,最高风险组100%(相对危险度7.67,P<.001)。
- 模型AUROCC为.774(95%CI .707-.841);增加3个额外预测因子后AUROCC为.805(95%CI .742-.867),准确性未显著提高。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文结论指出需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We sought to derive a risk score, DORM65, of known variables to predict the likelihood of a positive EUS in patients with idiopathic acute pancreatitis (IAP). METHODS: A retrospective cohort study of 180 patients with IAP was performed across 3 tertiary care centers between January 2018 and December 2021. Multivariate logistic regression modeling was performed to predict a positive EUS. Accuracy of the models was assessed by the area under the receiver-operating characteristic curve (AUROCC). RESULTS: The diagnostic yield of EUS was 58.9% (95% confidence interval [CI], 51.7-66.1). The DORM65 scores of 5 predictors present before EUS with the best discrimination were a delayed EUS (defined as ≥82 days from the last episode of AP), obesity, not having had a repeated transabdominal US, male sex, and age ≥65 years at the time of EUS. For those at the lowest risk score group, the positive EUS rate was 13.0% compared with 100% in those at the highest risk group (relative risk, 7.67; P < .001). A score of 3 or more had a positive predictive value of 86.0% with a sensitivity of 34.9% and specificity of 91.9%. The model had a high predictive accuracy (AUROCC, .774; 95% CI, .707-.841). Adding 3 additional predictors (no cholecystectomy, no MRCP, and a single episode of AP) did not increase the accuracy significantly (AUROCC, .805; 95% CI, .742-.867). CONCLUSIONS: DORM65 is easily calculated and accurately predicts a positive EUS in patients with IAP. Further validation is needed.
引用
- Cortés P, Kumbhari V, Antwi SO, et al. Simple risk score to predict the likelihood of a positive EUS in idiopathic acute pancreatitis. Gastrointest Endosc. 2022. PMID: 35850170. doi:10.1016/j.gie.2022.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。